Skip to content

The efficacy and safety of compound preparation of jujube extract in the treatment of iron deficiency anemia: a randomized controlled clinical trial

The efficacy and safety of compound preparation of jujube extract in the treatment of iron deficiency anemia: a randomized controlled clinical trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105535
Enrollment
Unknown
Registered
2025-07-04
Start date
2025-04-17
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron deficiency anemia characterized by low hemoglobin levels

Interventions

Control group:Participants take orally 250ml of enteral nutrition preparation, 10g of whey protein, and 50mg of iron gluconate daily.
Test group:Participants take oral enteral nutrition preparation (250ml), 10g whey protein, 50mg iron gluconate, and 10g jujube extract daily

Sponsors

Tianjin Anding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Hemoglobin concentration= 18 years old and < 65 years old.

Exclusion criteria

Exclusion criteria: 1. Anemia caused by immune factors and genetic factors, such as aplastic anemia and thalassemia, and anemia caused by toxic substances, physical factors and biological factors will also be excluded in this study; 2.Suffering from serious metabolic diseases (diabetes, obesity, hyperlipidemia, etc.), and/or liver, kidney, blood, urinary system, digestive tract diseases, infection or autoimmune diseases, malignant tumors, etc.; 3.Suffering from hematological disorders; 4.Individuals who have placed metal instruments (such as steel plates, steel nails, metal brackets, etc.) in their bodies, as well as those who are unable to perform human body composition analysis due to the presence of pacemakers; 5.Those who do not agree to sign the informed consent form.

Design outcomes

Secondary

MeasureTime frame
Serum ferritin;Red blood cell count;

Primary

MeasureTime frame
Hemoglobin concentration;

Countries

China

Contacts

Public ContactQi Xiang

Tianjin Anding Hospital

xiangqixiangqi@163.com+86 22 88188889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026